Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Valaciclovir in Hemodialysis Patients
NCT00343278Phase 4Completed
- Sponsor
- GSK
- Start
- Jul 2005
- Primary completion
- Aug 2005
- Modality
- Metabolically Activated Prodrugs
01
Overview
Phase 4, open-label, single-arm trial of valaciclovir in Viral diseases, sponsored by GSK. Primary endpoints: Pharmacokinetic parameters for VACV, ACV and CMMG at 48 hours and Relationship between ALDH2 genotypes and the pharmacokinetics of VACV, ACV and CMMG. Started Jul 2005; status: completed.
02
Drugs
valaciclovir
03
Conditions
Viral diseases
Beyond the preview
Go deeper on NCT00343278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343278.